Figure 36. KQ6 Withdrawals due to adverse events base case analysis—Meta-analys is of randomized placebo-controlled trials in patients with stable is chemic heart disease.

Figure 36KQ6 Withdrawals due to adverse events base case analysis—Meta-analys is of randomized placebo-controlled trials in patients with stable is chemic heart disease

Test for heterogeneity: Cochran Q=0.812526 (df=2) p=0.6661; I2 statistic=0%

From: Results

Cover of Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease [Internet].
Comparative Effectiveness Reviews, No. 18.
Coleman CI, Baker WL, Kluger J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.